Clague Laura 4
4 · Travere Therapeutics, Inc. · Filed Jan 26, 2022
Insider Transaction Report
Form 4
Clague Laura
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-01-24$24.98/sh−2,063$51,534→ 29,253 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.